Description
HEMLIBRA® 150 mg/mL es un medicamento anticuerpo monoclonal cuyo principio activo es Emicizumab
Contiene: Lanolina
Anemia por trastornos hematológicos bajo indicación médica
SUSTANCIA: CICLOFERON SUSP
Dosis: 44 microgramos
DEXTREVIT INY. I.V. CAJA C/2 FCOS. AMP. C/10 ML. ANTICUERP INSULINA HEMLIBRA® 150 mg/mL es unSUSTANCIA: DEXTREVIT INY. I. V. CAJA C 2 FCOS. AMP. C 10 ML. FABRICANTE: GROSSMAN
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
